Expressão de PRSS11, MTSS1, CLPTM1, SMYD2, NOTCH1 e RPL37A em fatias de carcinoma de mama de cadelas e correlação com resposta à doxorrubicina in vitro

@inproceedings{Sobral2006ExpressoDP,
  title={Express{\~a}o de PRSS11, MTSS1, CLPTM1, SMYD2, NOTCH1 e RPL37A em fatias de carcinoma de mama de cadelas e correlaç{\~a}o com resposta {\`a} doxorrubicina in vitro},
  author={R. Sobral},
  year={2006}
}
View via Publisher
teses.usp.br

References

SHOWING 1-10 OF 78 REFERENCES
PREVALÊNCIA DE NEOPLASIAS E MODALIDADES DE TRATAMENTOS EM CÃES, ATENDIDOS NO HOSPITAL VETERINÁRIO DA UNIVERSIDADE FEDERAL DO PARANÁ
Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance.
High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival.
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
A novel gene, CRR9, which was up-regulated in CDDP-resistant ovarian tumor cell line, was associated with apoptosis.
Differential expression analysis of MIM (MTSS1) splice variants and a functional role of MIM in prostate cancer cell biology.
TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patients.
Expression and regulation of MIM (Missing In Metastasis), a novel putative metastasis suppressor gene, and MIM-B, in bladder cancer cell lines.
c-erbB-2 expression and nuclear pleomorphism in canine mammary tumors.
Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer
...
1
2
3
4
5
...